ReviewJournal of translational medicine2026
Neuroinflammation after stroke: initiation, amplification and therapeutic prospects.
Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundStroke is one of the leading causes of death and long-term disability worldwide, placing a significant health and economic burden on society. Despite significant advancements in acute reperfusion therapy, the narrow treatment window makes it challenging for many patients to get the help they need. The pathophysiological core of post-stroke brain injury lies in the cascade of neuroinflammation amplification initiated by the activation of innate immune cells that release a variety of inflammatory mediators, forming a positive feedback loop that keeps amplifying inflammatory signals. This uncontrolled and self-sustaining excessive inflammation, a major driver of secondary neuronal injury, also contributes to neurological deficits. Therefore, it is crucial to understand how neuroinflammation is initiated.
objectiveThis review aims to systematically elucidate the initiation mechanisms and cascade amplification effects of neuroinflammation after stroke, revealing how glial cell metabolic reprogramming triggered by damage-associated molecular patterns (DAMPs) drives blood-brain barrier (BBB) disruption and peripheral immune cell infiltration. It also focuses on the interactive crosstalk between inflammation and various cell death pathways, analyzing the molecular mechanisms that form a vicious cycle and exacerbate secondary brain injury. Furthermore, by reviewing existing intervention strategies targeting neuroinflammation, this paper discusses clinical translation barriers such as patient heterogeneity and drug delivery efficiency, with the goal of providing a theoretical foundation and strategic reference for the precise intervention of post-stroke neuroinflammation.
conclusionIn the future, as single-cell sequencing and multi-omics analysis techniques become more widely available, researchers will be able to more systematically clarify the spatiotemporal dynamics and individual heterogeneity of neuroinflammation mechanisms. The findings included in this review could make a difference in moving relevant basic research into clinical applications and offer important insights for developing new, precise and effective targeted treatments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.